>>> US Gapping up

Gapping up
In reaction to earnings/guidance:

PSFE +13.9%, HROW +12.8%, ONON +10%, ALC +9.2%, SE +7%, ALLO +6.9% (also prices common stock offering), INFN +5%, VYGR +4.7%, IGT +3.6%, VOD +3.4%, PACS +2.9%, SONY +2.8%, AGYS +1.5%, MAG +1.4%, SFL +1.1%

Other news:

AMC +87.7% (completed its previously disclosed "at-the-market" equity offering launched on March 28, 2024; AMC raised approximately $250 mln of new equity capital through the sale of 72.5 mln shares at $3.45/share)
SPWR +61.8% (delays 10-Q filing)
LXRX +4.3% ( New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction)
CDXS +3.9% (presents groundbreaking enzymatic synthesis data at TIDES USA annual meeting)
LBAI +3.8% (Lakeland Bancorp and Provident (PFS) expect to close the Merger Transaction after the close of trading on May 15)
STLA +2.4% (talks with VALE to buy nickel smelter, according to FT.com)
CLNE +2.4% (Clean Energy Fuels and Maas Energy Works announce a new joint development agreement to build nine renewable natural gas (RNG) production facilities at dairy farms across seven states)
STXS +2.3% (to acquire Access Point Technologies EP)
HCM +0.9% (Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China; Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab)

Analyst comments: